Eli Lilly CEO David Ricks aims to negotiate Mounjaro's inclusion in Australia's Pharmaceutical Benefits Scheme despite a prior deal collapse over pricing. Rosie O'Donnell shared her experience with Mounjaro, initially fearing cancer due to rapid weight loss.